VIM and pancreatic ductal adenocarcinoma: <h4>Background</h4>Vimentin, a key component of the epithelial-to-mesenchymal transition (EMT), has been mechanistically implicated in the progression and poor prognosis of pancreatic ductal adenocarcinoma (PDAC).